Taiwan - Cina - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

科懋生物科技股份有限公司 台北市南港區忠孝東路7段508號5樓 (23024594) - stiripentol - 粉劑 - stiripentol (2803017000) mg - stiripentol - 用於嬰兒期嚴重肌痙攣性癲癇(semi, dravet's syndrome)病人，僅服用clobazam及valproate無法充分控制癲癇發作時，併用diacomit作為輔助治療難治的全身性強直陣攣性發作(generalized tonic-clonic seizure)。

Taiwan - Cina - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

科懋生物科技股份有限公司 台北市南港區忠孝東路7段508號5樓 (23024594) - stiripentol - 膠囊劑 - stiripentol (2803017000) mg - stiripentol - 用於嬰兒期嚴重肌痙攣性癲癇(semi, dravet's syndrome)病人，僅服用clobazam及valproate無法充分控制癲癇發作時，併用diacomit作為輔助治療難治的全身性強直陣攣性發作(generalized tonic-clonic seizure)。

Finland - Finland - Fimea (Suomen lääkevirasto)

biocodex - stiripentolum - kapseli, kova - 250 mg - stiripentoli

Finland - Finland - Fimea (Suomen lääkevirasto)

biocodex - stiripentolum - kapseli, kova - 500 mg - stiripentoli

Finland - Finland - Fimea (Suomen lääkevirasto)

biocodex - stiripentolum - jauhe oraalisuspensiota varten - 250 mg - stiripentoli

Finland - Finland - Fimea (Suomen lääkevirasto)

biocodex - stiripentolum - jauhe oraalisuspensiota varten - 500 mg - stiripentoli

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - primidone, quantity: 250 mg - tablet, uncoated - excipient ingredients: carmellose calcium; povidone; gelatin; magnesium stearate; stearic acid - management of grand mal and psychomotor (temporal lobe) epilepsy. it is also of value in the management of focal or jacksonian seizures, myoclonic jerks and akinetic attacks.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - stiripentol 250mg;   - capsule - 250 mg - active: stiripentol 250mg   excipient: erythrosine   gelatin   indigo carmine   ink black 10a2 magnesium stearate povidone sodium starch glycolate titanium dioxide   - indicated for adjunctive treatment of generalised tonic-clonic and clonic seizures associated with severe myoclonic epilepsy in infancy (smei, also known as dravet syndrome) in patients whose seizures are not adequately controlled with a benzodiazepine (usually clobazam) and valproate.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - stiripentol 500mg;   - capsule - 500 mg - active: stiripentol 500mg   excipient: gelatin   ink black 10a2 magnesium stearate povidone sodium starch glycolate titanium dioxide   - indicated for adjunctive treatment of generalised tonic-clonic and clonic seizures associated with severe myoclonic epilepsy in infancy (smei, also known as dravet syndrome) in patients whose seizures are not adequately controlled with a benzodiazepine (usually clobazam) and valproate.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - stiripentol 250mg;   - powder for oral suspension - 250 mg - active: stiripentol 250mg   excipient: aspartame carmellose sodium erythrosine hyetellose spray-dried glucose liquid povidone sodium starch glycolate titanium dioxide tutti frutti flavour 25h245 - indicated for adjunctive treatment of generalised tonic-clonic and clonic seizures associated with severe myoclonic epilepsy in infancy (smei, also known as dravet syndrome) in patients whose seizures are not adequately controlled with a benzodiazepine (usually clobazam) and valproate.